Learning Objectives:

  1. Review the general approach to evaluating thyroid dysfunction associated with amiodarone
  2. Discuss the spectrum of thyroid dysfunction, including hypothyroidism, thyrotoxicosis, and other thyroid abnormalities
  3. Discuss treatment options for amiodarone-induced thyroid dysfunction and related clinical scenarios

and

1. Discuss the presentation of subacute adrenal insufficiency

2. Discuss the endocrine effects of immune checkpoint therapies

Session date: 
11/07/2024 - 4:30pm to 5:30pm CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Fawsia Osman, M.D., and Rachel Umans, M.D.